Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria

Metallo-β-lactamase (MBL)-producing Gram-negative bacteria are often extremely resistant, leading to a real therapeutic dead end. Here, we evaluated the in vitro and in vivo efficacy of aztreonam in combination with ceftazidime-avibactam, ceftolozane-tazobactam, or amoxicillin-clavulanate for the tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Emeraud, Cécile, Escaut, Lelia, Boucly, Athénaïs, Fortineau, Nicolas, Bonnin, Rémy A., Naas, Thierry, Dortet, Laurent
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2019
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496057/
https://ncbi.nlm.nih.gov/pubmed/30858212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00010-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars